About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,006 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,006 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2201-2220 of 13,006 trials

CompletedOptical Frequency Domain Imaging (OFDI) and Vascular Healing After Stent PlacementThe use of drug eluting stents (DES) used to treat coronary artery blockages is limited by poor healing of the stented area.NCT01794949·Atlanta, Georgia CompletedSafety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)Acute Spinal Cord Injury (SCI) is a rare injury that leads to permanent neuromotor impairment and sudden disability.NCT04295538·Sacramento, California and 40 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

RecruitingA Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseThis Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also…NCT06819878·Dothan, Alabama and 373 others

CompletedEfficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic AsthmaA substance called immunoglobulin E (IgE), which is naturally produced by our body, has a key role in generating asthma attacks.NCT00079937·Birmingham, Alabama and 55 others

CompletedTopically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisSuppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects with Moderate to Severe Plaque Psoriasis.NCT03058744·Anaheim, California and 11 others

CompletedTherapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] TrialCardiac arrest is a sudden, unexpected loss of heart function.NCT00878644·Birmingham, Alabama and 33 others

TerminatedAntepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean SectionThis is a randomized, multicenter, double blind, placebo controlled trial of betamethasone versus a placebo given prior to the mothers at term and near term gestation (\>34 and…NCT00139256·Atlanta, Georgia

CompletedLCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)This multi-center study will compare the effectiveness of adding virtual peer mentoring (PM) to a structured education-based (STE) transition program for emerging adults with…NCT03593395·Birmingham, Alabama and 13 others

UnknownANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation StudyThis double-blind, placebo-controlled, dose-finding study is designed to identify the lowest AGI-1067 dose that improves glycemic control as measured by HbA1c and fasting glucose…NCT00525577·Stockbridge, Georgia and 89 others

UnknownIluvien Registry Safety StudyThe study will include any patient treated with Iluvien at designated sites in European countries where marketing authorization has been granted in order to obtain broader safety…NCT01998412·Atlanta, Georgia

CompletedA Study of DOX-SL in the Treatment of AIDS-Related Kaposi's SarcomaTo evaluate the safety and effectiveness of Stealth liposomal doxorubicin hydrochloride (DOX-SL) in the long-term treatment of AIDS-related Kaposi's sarcoma (KS) in patients who…NCT00002319·Berkeley, California and 32 others

Active not recruitingPembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or MedulloblastomaThis phase I trial studies the side effects and best dose of pembrolizumab and to see how well it works in treating younger patients with high-grade gliomas (brain tumors that are…NCT02359565·Los Angeles, California and 11 others

CompletedDasotraline SEP360-105 Pediatric PK/PD StudyPediatric PK study of SEP-225289 (Dasotraline)NCT02195167·Little Rock, Arkansas and 11 others

CompletedCo-administration of Olodaterol Respimat® and Tiotropium Handihaler®The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat®…NCT01694771·Florence, Alabama and 89 others

CompletedSurveillance Trial to Evaluate a Shortened Infusion Time of Intravenous IbuprofenThe primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the…NCT01334944·San Diego, California and 12 others

CompletedStudy of Vedolizumab in Patients With Moderate to Severe Crohn's DiseaseThis study in patients with moderately to severely active Crohn's disease is designed to establish the efficacy and safety of vedolizumab for the induction of clinical response…NCT01224171·Lafayette, Colorado and 40 others

CompletedCombo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis RegimensThe study will determine tissue pharmacology of a single dose of doxycycline for sexually transmitted infection (STI) Post-exposure Prophylaxis (PEP).NCT04860505·Atlanta, Georgia

CompletedStudy to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic DisorderCV185118 is a single dose Apixaban PK/PD study in pediatric participants.NCT01707394·Little Rock, Arkansas and 26 others

Active not recruitingA Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)This is a study of the safety and tolerability of oral miransertib (MK-7075) administered to participants at least 2 years of age with phosphatidylinositol-4,5-bisphosphate…NCT04980872·Atlanta, Georgia and 10 others

CompletedA 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a PlaceboThe purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of…NCT00201981·Birmingham, Alabama and 62 others

PreviousPage 111 of 651Next

in Atlanta

Heart Diseasein Atlanta